Champions Oncology Inc. | Mutual Funds
Mutual Funds that own Champions Oncology Inc.
Vanguard Total Stock Market Index Fund
108,290
0.99%
16,600
0%
07/31/2018
Altair Smaller Companies Fund
84,017
0.77%
84,017
0.22%
02/28/2018
Vanguard Extended Market Index Fund
59,932
0.55%
0
0%
07/31/2018
iShares Micro Cap ETF
15,974
0.15%
0
0.01%
09/06/2018
Fidelity Nasdaq Composite Index
7,123
0.07%
0
0%
07/31/2018
Bridgeway Ultra Small Company Fund
6,861
0.06%
6,861
0.06%
12/31/2017
Vanguard Balanced Index Fund
1,100
0.01%
0
0%
07/31/2018
| Address |
One University Plaza
Hackensack New Jersey 07601
United States
|
|
Employees
|
- |
| Website |
http://www.championsoncology.com |
| Updated |
07/08/2019 |
| Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. |
